Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
200 | 3 | ONCOLOGY//PACLITAXEL//THYMIDYLATE SYNTHASE | 52806 |
978 | 2 | 5 FLUOROURACIL//DIHYDROPYRIMIDINE DEHYDROGENASE//THYMIDINE PHOSPHORYLASE | 10904 |
1361 | 1 | OXALIPLATIN//METASTATIC COLORECTAL CANCER//IRINOTECAN | 2708 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | OXALIPLATIN | authKW | 997426 | 16% | 19% | 446 |
2 | METASTATIC COLORECTAL CANCER | authKW | 910618 | 9% | 31% | 249 |
3 | IRINOTECAN | authKW | 680640 | 13% | 17% | 346 |
4 | ADVANCED COLORECTAL CANCER | authKW | 575912 | 4% | 50% | 99 |
5 | CAPECITABINE | authKW | 482450 | 9% | 16% | 255 |
6 | COLORECTAL CANCER | authKW | 297819 | 28% | 3% | 755 |
7 | LEUCOVORIN | authKW | 271646 | 4% | 21% | 112 |
8 | FOLFIRI | authKW | 260899 | 2% | 39% | 58 |
9 | BEVACIZUMAB | authKW | 257910 | 11% | 7% | 305 |
10 | RALTITREXED | authKW | 244585 | 2% | 36% | 58 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 58587 | 75% | 0% | 2032 |
2 | Gastroenterology & Hepatology | 979 | 6% | 0% | 172 |
3 | Pharmacology & Pharmacy | 562 | 11% | 0% | 294 |
4 | Surgery | 323 | 8% | 0% | 219 |
5 | Medicine, General & Internal | 267 | 6% | 0% | 170 |
6 | Health Care Sciences & Services | 161 | 2% | 0% | 57 |
7 | Geriatrics & Gerontology | 86 | 1% | 0% | 34 |
8 | Health Policy & Services | 47 | 1% | 0% | 26 |
9 | Hematology | 8 | 1% | 0% | 38 |
10 | Nursing | 3 | 1% | 0% | 14 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | GERCOR | 77571 | 0% | 67% | 10 |
2 | MED ONCOL | 61150 | 19% | 1% | 512 |
3 | SERV MALAD SANGUINES IMMUNITAI TUMORALES | 41556 | 0% | 71% | 5 |
4 | KENT CANC | 31028 | 0% | 67% | 4 |
5 | DIGEST ONCOL UNIT | 29697 | 1% | 11% | 23 |
6 | MED ONCOL SERV | 28941 | 3% | 3% | 74 |
7 | MED ONCOL UNIT | 27544 | 3% | 3% | 70 |
8 | SERV MED INTERNE ONCOL | 27456 | 1% | 17% | 14 |
9 | MODULO ONCOL | 26181 | 0% | 75% | 3 |
10 | CLIN TRIAL PHARMACOL | 23273 | 0% | 100% | 2 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CLINICAL COLORECTAL CANCER | 237307 | 4% | 20% | 104 |
2 | ANNALS OF ONCOLOGY | 45417 | 7% | 2% | 182 |
3 | JOURNAL OF CLINICAL ONCOLOGY | 18180 | 6% | 1% | 161 |
4 | ONCOLOGY | 12222 | 2% | 2% | 65 |
5 | ONCOLOGY-NEW YORK | 11669 | 1% | 3% | 39 |
6 | EUROPEAN JOURNAL OF CANCER | 11295 | 4% | 1% | 100 |
7 | SEMINARS IN ONCOLOGY | 9927 | 2% | 1% | 67 |
8 | JOURNAL OF GERIATRIC ONCOLOGY | 9207 | 1% | 5% | 17 |
9 | ONCOLOGIST | 8344 | 2% | 2% | 41 |
10 | ANTI-CANCER DRUGS | 6977 | 2% | 1% | 45 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | OXALIPLATIN | 997426 | 16% | 19% | 446 | Search OXALIPLATIN | Search OXALIPLATIN |
2 | METASTATIC COLORECTAL CANCER | 910618 | 9% | 31% | 249 | Search METASTATIC+COLORECTAL+CANCER | Search METASTATIC+COLORECTAL+CANCER |
3 | IRINOTECAN | 680640 | 13% | 17% | 346 | Search IRINOTECAN | Search IRINOTECAN |
4 | ADVANCED COLORECTAL CANCER | 575912 | 4% | 50% | 99 | Search ADVANCED+COLORECTAL+CANCER | Search ADVANCED+COLORECTAL+CANCER |
5 | CAPECITABINE | 482450 | 9% | 16% | 255 | Search CAPECITABINE | Search CAPECITABINE |
6 | COLORECTAL CANCER | 297819 | 28% | 3% | 755 | Search COLORECTAL+CANCER | Search COLORECTAL+CANCER |
7 | LEUCOVORIN | 271646 | 4% | 21% | 112 | Search LEUCOVORIN | Search LEUCOVORIN |
8 | FOLFIRI | 260899 | 2% | 39% | 58 | Search FOLFIRI | Search FOLFIRI |
9 | BEVACIZUMAB | 257910 | 11% | 7% | 305 | Search BEVACIZUMAB | Search BEVACIZUMAB |
10 | RALTITREXED | 244585 | 2% | 36% | 58 | Search RALTITREXED | Search RALTITREXED |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |